News
Oprah Winfrey and Elon Musk endorsed it. And though Indian celebrities haven’t yet admitted to their use, the mystery slimming of Bollywood filmmaker Karan Johar and TV talk show host Kapil Sharma ...
Rochelle McDonald has just been through the messiest of break-ups. “Guzman y Gomez were devastated,” she says, but 17 kilos ...
1don MSN
Scientists have discovered novel drug candidates which could ultimately lead to new effective treatments for conditions ...
13d
American Woman on MSNWhere to Buy the Best USA Made Peptides in 2025?Peptides are gaining a lot of attention in various fields of research- medicine, biology, and cosmetics sciences- much i ...
15d
India Today on MSNWegovy weight-loss drug now in India: How it works and who should take itNovo Nordisk has introduced Wegovy, a once-weekly weight loss injection, in India. The drug aims to manage obesity and reduce ...
MariTide, a new drug from Amgen, helped some people with obesity lose up to 20% of their body weight. In a phase 2 trial, a new GLP-1 drug helped people lose up to 20% of their body weight over a year ...
6d
The Print on MSNObesity care in India is evolving—no longer just diets & surgery, it’s all about multi-specialty approachAs obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised ...
Investing.com -- Bank of America (NYSE: BAC) has unveiled its top 10 U.S. Ideas for the third quarter of 2025, featuring eight Buy-rated stocks and two Underperform calls across ten industries.
Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. While Novo lost share to Eli Lilly's once-weekly Trulicity, Ozempic and Rybelsus ...
Dr. Daniel Benhuri, a board-certified internal medicine physician and highly rated concierge doctor in Beverly Hills, is now offering a full range of advanced peptide therapies designed to support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results